Welcome to Anti Aging Fruits

Opening Hours : Monday to Saturday - 8am to 9pm
  Contact : (760) 481-8800

All Posts in Category: Uncategorized

RISKS OF LOW HGH FOR BOTH MEN AND WOMEN

anti-aging-banner

Risks associated with low Human Growth Hormone for Men and Women

                                          Dr. Larry Sosna N.D. PhD HHP

 

Men and women who suffer from low human growth hormone (HGH) can have extremely severe symptoms.

Please understand that the pituitary gland is called the master gland of the entire Endocrine System…that essentially means the pituitary is responsible one way or another for how all the hormones are produced and how they function.

The human body has a communication system called homeostasis which is designed to keep all structures and functions within the human body at a so called normal range. Average normal temperature is 98.6 and blood pressure is well functioning at 120/80. There is according to the laws of homeostasis a normal for virtually everything in the human body.

There is a key involved in all this homeostasis. Obviously my toe is not as important as my heart or brain so in moments of stress ones tow may forego for a few minutes some blood flow while the heart is instructed to beat somewhere between 60 and 98 beats per min.

The key most important key in homeostasis is called the Adrenal, Hypothalamic, Pituitary Axis.

Many scientists will argue this is the control panel for the entire human body just the way an advanced jet plane has a sophisticated control panel and if it does not work correctly we might not safely get back to the ground.

Think of all this as you’re potential for superb excellent health as scientists have learned much about helping out the human control panel to work and function in a greatly improved manner.

Conversely, if the anterior pituitary is not making enough (HGH) human growth hormone a massive aspect of the human control panel is malfunctioning.

We know this by a set of symptoms and by seeing a blood count of IGF-1 too low.

Sometimes, symptoms are very pronounced but IGF-1 levels seem ok….Research doctors in the field virtually always agree that vast symptoms trump a number on a test.

HGH is so important it takes up one half of the entire pituitary gland and in that half the anterior section HGH and only HGH is made. Established high level of Importance.

Functions:

Proper levels of HGH allow for all cell repair and regeneration.

It does this by activating and instructing each type of tissue like heart tissue

Or lung tissue or skin tissue to find the tissue growth factor in each type of tissue

And HGH tells all of those super important tissue growth factors to get ready and gear up to repair and regenerate.

When we get older HGH falls and once it falls too low and that can even happen to a 35 year old

If they have had way too much stress and illness in life.

So it is a great THREAT to the body not to able to complete tissue repair and regeneration.

In time scientists know that can lead to smaller organs and age related diseases of all kinds.

 

There are special symptoms and threats from Low HGH that apply to Women:

Women are very special in that they can carry on and bring forth new children. To be capable of doing such a daunting task nature gave women under her skin 2 layers of fat tissue. Fat is a living tissue. Nature gave women this extra layer that men do not have to preserve our species the human family…for in times when food is scarce and a woman is with child she may have to give up the entire second layer which surrounds the entire body just to give the baby a chance of living.

When women become low in HGH they are usually at an age when their other hormones are getting too low as well. Low HGH in women causes the second layer of fat to thicken and that is not good for the cardiovascular system, blood pressure and can even start the beginning of what is known as fatty liver disease.

Unfortunately, women lose progesterone 12 years before she starts to lose estrogen. A women losing both progesterone, and is say 40 and also losing estrogen is in all likelihood low in HGH and when proven so she is at much greater risk from cardiac issues then a man.

After menopause it has been well documented that women are at a higher rate for both heart attacks and strokes, one of the reasons why is low HGH which is highly protective of the heart and brain when HGH is optimized to more youthful levels by the addition of HGH therapy. One can avail themselves of much greater cardiovascular protection.

It may sound like a small thing but low HGH in women can be responsible for thinning hair, dry hair and dry skin. Also with low HGH women cannot grow longer nails….again to most women that is not a joke or a small matter.

Originally women in the course of life made a bit more HGH from their pituitary gland but even perimenopause will create a homeostatic signal to make less HGH and thus women start to lose collagen and elastin so needed for healthy arteries as well as joint function.

Another aspect, is when women have low HGH, there is a decline in L-Dopamine. This neurotransmitter is vital for the pleasure response, including the ability to enjoy sexual activity. Why? Because L-Dopamine levels need to be high enough to make Oxytocin, which most definitely is needed for mood elevation and sexual desire.

Low HGH in women means they are subject to early bone loss as it is HGH that creates new bone cells, osteoporosis is a terrible burden, it is very painful and once it starts the only thing that can change it course fully is to restore HGH levels, back to a more youthful level. When it is has gone too far and HGH has been too low for too long that is when women get that hump curved shape to the upper spine. Women this is 100% avoidable with restored youthful levels of HGH but one must start at the correct time.

Women, who start just before perimenopause say at age 36, are so different looking than their counterparts who have not done this. They have wonderful muscle tonality, their skin looks youthful, and there is an undefinable ineffable golden glow that shows in their face…after all these years I can almost always spot women who took action and availed herself of HGH before premature aging.

Read More

Are we on the Verge of Curing Cancer?

synthetic-chemicals-1024x768

                         Are We on the Verge of Curing Cancer?

I have always viewed cancer as a radical illness that needs a wide range of different kinds of treatments. This excellent article featured on CNN is just what I have been talking about using Immune-Therapy from your own body to kill off cancer tumors before they overwhelm the body.       Larry Sosna N.D. PhD HHP

 

Source: CNN

Fighting cancer by targeting its ‘Achilles’ heel’ 01:51

Story highlights

  • Scientists have discovered possible new ways to attack core mutations in a patient’s cancer cells
  • There are several limitations, including cost and the speed at which treatments could be developed

(CNN)A new breakthrough in cancer research could lead to a novel form of cancer treatment — one that is highly specialized for each patient.

Researchers discovered that even though cancer cells mutate wildly within a person’s body, the cancer cells within each patient also have common mutations — ones that could be isolated and fought off by certain immune cells.

Think of it this way: A patient’s cancer cells all start off with the same tree trunk, but then grow different kinds of branches. The new research shows certain immune cells can “chop the tree at the trunk rather than just pruning the branches,” Dr. Sergio Quezada told CNN.

WHO urges cancer prevention 02:42

Quezada, from the University College London’s Cancer Institute, co-authored the study, which was published Thursday by Science magazine.

For years, one of the biggest obstacles in fighting cancer has been the fact that a tumor’s cancer cells are not all the same.

“The tumor is an evolving mass. Mutations change here and there. Mutations in one area of the tumor are usually different from mutations in other parts of the tumors,” Quezada said.

Read: These dogs can sniff out cancer better than some tests

In a statement to Cancer Research UK, he likened the fight against cancer to police chasing a wide array of criminals.

“The body’s immune system acts as the police trying to tackle cancer, the criminals. Genetically diverse tumours are like a gang of hoodlums involved in different crimes — from robbery to smuggling. And the immune system struggles to keep on top of the cancer — just as it’s difficult for police when there’s so much going on,” he said.

“Our research shows that instead of aimlessly chasing crimes in different neighborhoods, we can give the police the information they need to get to the kingpin at the root of all organized crime — or the weak spot in a patient’s tumor — to wipe out the problem for good.”

What this means for treatment

Quezada told CNN this discovery could lead to two kinds of treatment:

1) Making customized vaccines to target the core mutations in each patient.

2) Identifying which immune cells, or T-cells, can fight off those core mutations, then multiplying those T-cells in a lab.

Quezada said the customized vaccines would be “the ultimate personalized form of therapy.”

Billionaire behind Cancer Moonshot 2020 02:49

“This would mean basically taking a cancer tumor, finding the trunk, and then designing a vaccine (to) inject in the patent,” he said.

“The second approach is to ‘fish’ these cells — T-cells — that recognize the trunk, expand them outside the patient” and inject them in the body.

Quezada said no human trials have started using either approach in light of the study, but said he hopes trials will begin within five years.

Read: Blindsided by cancer? 5 things to do

The limitations

But the discovery doesn’t mean all cancer patients will be cured soon. The potential for new treatment also has several limitations.

First is “the speed at which you can generate personalized therapy,” Quezada said. “Some cancers go really fast.”

Pharmaceutical CEO speaks about $1 cancer drug 03:32

Developing a customized vaccine, for example, could take more time than a cancer patient has.

Second, it would be expensive. Quezada said he doesn’t have an estimate on how much either type of treatment would cost, but given the highly customized nature of each, it could be extremely expensive.

“That’s going to be an important point of this discussion,” he said.

Finally, such treatments would likely work better for some types of cancer than others. Quezada said he believes lung cancer and melanoma would be the most likely to respond well to such treatment.

Read: Why cancer drugs worth $3B are wasted

A massive collaboration

A team of 36 international researchers worked on the study, which included scientists from the London, the United States, Denmark and Germany. The study was funded by Cancer Research UK and the Rosetrees Trust.

“It’s the most amazing collaboration I’ve ever worked on, Quezada said. “It’s been an amazing roller coaster.”

The next roller coaster will be determining when patients could receive the treatments — and learning how well they might work.

CNN’s Dominique Heckels contributed to this report.

 

 

Read More

Healing Injured Spinal Discs

Healing Injured Spinal Discs even ones which have Herniated

Larry Sosna N.D. PhD HHP

There have literally been several hundred peer reviewed research articles on how Human Growth Hormone works to regenerate all cells, tissues and organs, in the human body. The process is a very elegant one which gives rise to a much greater understanding of how the human body heals itself after injuries. In general this is how the HGH system of bodily healing and repair works.

If a person has youthful blood levels of HGH any injury anywhere sends out signals through the biofeedback communication loops to send HGH to the liver were IGF-1 is made. IGF-1 signals all the cells, tissues and organs of the body to release its specific Embryonic Tissue Growth Factors (ETGF.) The ETGF mobilize to do protein synthesis to the point where the tissues build up until repair is complete. Let’s look at a small example and then we can look at something which almost everyone needs repair and healing of…that being the discs of the spine… as many millions of people have hurt their backs…I have heard estimates can go as high as 3 out of 4 people in their life time have had painful back problems. First, allow me to get back to the small example of HGH in the healing process.

 

You are cooking and using a sharp knife to cut vegetables, time is of the essence and you cut faster then suddenly you go ouch! I cut my finger. You quickly clean the wound and then you notice it is a real cut but not down to the bone. In this case, it is called healing by first Intension, which means you will not need stitches and there will be a very little scar that with enough time will fade away completely. In this and all other cases what proceeds is exactly what I described above… Please notice how the very youthful heal from a cut finger much faster than a person 50 or 60 this is because at age 50 most folks are making roughly 70% less HGH than a person 18 years old. BUT, and I have experienced this for myself many times as have many other folks 40 and up who take shots of HGH to get  back to youthful blood levels of HGH… my finger cut will heal very quickly. I, and many of my clients on HGH report the very same thing…cuts heal about twice as fast as a person age 40 and up who does not take injections of HGH. The reason for this small example is I cut my finger with a very sharp knife I was making dinner about 4 days ago… when a friend called out to me  I turned my head to look at her and the next thing I knew blood was all over my kitchen floor. I have personally been on supplemental injections of HGH for 23 years and in just 4 days a fairly deep cut is almost completely gone.

 

Let’s look at the HGH healing formulation again. Youthful blood levels of HGH = a speedy regeneration of all types of wounds including rebuilding new discs which have been wounded through herniation of the disc. Once again, please allow me to illustrate how to regenerate a new healed disc from an old injured one.

What are the discs subcomponents? In other words what is the disc made of? Problematically, it is made of Fibrocartilage. Why do I say it is problematic? Because, Cartilage has no vascularity and thus no blood supply to quickly bring in the embryonic Mesenchyme Tissue Growth Factor and HGH which does regenerate Cartilage, BUT very slowly. Why? Because without a blood supply, Cartilage must get all nutrients and healing Growth Factors plus IGF-1 through the very slow process of osmosis. How did I learn to make the process go faster? First, by heating the affected disc with hot packs for 25 min each day, This gets more blood into the affected area .Next I showed folks how repeated soft movement 5 to 6 times a day makes the process of osmosis go much faster. Why? Because correct movement is like a pump…pumping all the healing agents mentioned above through the disc. Thus if you are one of the many millions who have injured discs and you want to regenerate them as I have for myself one will need to avail themselves of both HGH and Embryonic Mesenchyme Growth Factor which you can obtain right here at the SOSNA ANTI-AGING Rejuvenation Center…where we not only deeply care for all of our family of clients…BUT we also engage in the most cutting edge regenerative protocols… which is why we justly say about competition…They may be catching on but they are NOT catching up. It is our unyielding commitment to ourselves and to you are family of clients we care for.

 

Peer Reviewed References

·         Evaluation of patient satisfaction with second intention healing versus primary surgical closure

  • Journal of the American Academy of Dermatology,Volume 73, Issue 5, November 2015, Pages 865-867.e1
  • William G. Stebbins, Julia Gusev, H. William Higgins II, Andrew Nelson, Usha Govindarajulu, Victor Neel

 

 

Zone-specific integrated cartilage repair using a scaffold-free tissue engineered construct derived from allogenic synovial mesenchymal stem cells: Biomechanical and histological assessments.

Fujie H, Nansai R, Ando W, Shimomura K, Moriguchi Y, Hart DA, Nakamura N.

J Biomech. 2015 Oct 19. pii: S0021-9290(15)00563-1. doi: 10.1016/j.jbiomech.2015.10.015. [Epub ahead of print]

 

Journal of Biological Chemistry 2003, Oct,24 Shi-Wen X, Abraham D.J. Denton C, Black, CM.

 

Effect of Human Adipose Tissue Mesenchymal Stem Cells on the Regeneration of Ovine ArticularCartilage.

Zorzi AR, Amstalden EM, Plepis AM, Martins VC, Ferretti M, Antonioli E, Duarte AS, Luzo AC, Miranda JB.

Int J Mol Sci. 2015 Nov 9;16(11):26813-26831.

 

Synergistic effect of ascorbic acid and collagen addition on the increase in type 2 collagen accumulation incartilage-like MSC sheet.

Sato Y1Mera H2,3Takahashi D4Majima T5Iwasaki N4Wakitani S6Takagi M7.

Author information

  • 1Division of Biotechnology and Macromolecular Chemistry, Graduate School of Engineering, Hokkaido University, Kita-ku, N13W8, Sapporo, 060-8628, Japan.
  • 2School of Health and Sports Sciences, Mukogawa Women’s University, 6-46 Ikebiraki, Nishinomiya, Hyogo, 663-8558, Japan.
  • 3Foundation for Biomedical Research and Innovation, International Medical Device Alliance, 1-6-5, Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.
  • 4Department of Orthopaedic Surgery, Graduate School of Medicine, Hokkaido University, Kita-ku, N15W7, Sapporo, 060-8638, Japan.
  • 5Department of Joint Replacement and Tissue Engineering, Graduate School of Medicine, Hokkaido University, Kita-ku, N15W7, Sapporo, 060-8638, Japan.
  • 6Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 739-8553, Japan.
  • 7Division of Biotechnology and Macromolecular Chemistry, Graduate School of Engineering, Hokkaido University, Kita-ku, N13W8, Sapporo, 060-8628, Japan.

Mesenchymal stem cells: clinical applications and biological characterization

Received 22 September 2003, Revised 30 October 2003, Accepted 3 November 2003, Available online 24 January 2004

 

Volume 28, Issue 8, August 2000, Pages 875–884

Review

Mesenchymal stem cells: Biology and potential clinical uses

Annemarie B. Moseley

Read More

The Power of D-Ribose How to make Pure Energy in every Human Cell

 

By Dr. Larry Sosna N.D. PhD HHP

SOSNA LABORATORIES® 02/2015  Corvalen® Chews are an all natural D-ribose supplement clinically proven to help restore and replenish core energy. D-ribose is a natural pentose sugar that is designed for the support of cardiovascular health, fatigue, energy production, and mitochondrial function†. Corvalen® chewable tablets are great tasting with natural orange/vanilla flavoring sweetened with xylitol, and readily absorbed into the body. FUNCTIONS Corvalen® contains pure D-ribose, a safe and clinically researched ingredient that supports the natural way our bodies produce adenosine triphosphate (ATP), the energy currency of the cell. †Ribose is the vital structural backbone of critical cellular compounds called purines and pyrimidines. Our bodies must have an adequate supply of purines and pyrimidines to form major cellular constituents such as our genetic material (DNA and RNA), numerous cofactors, certain vitamins, and, importantly, adenosine triphosphate (ATP). Ribose is the starting point for the synthesis of these fundamental cellular compounds, and the availability of ribose determines the rate at which they can be made by our cells and tissues. D-ribose is a structural component of DNA, RNA, ATP, GTP, flavins (FAD, riboflavin) and other important nucleotides found in all living cells. Ribose is formed naturally via the pentose phosphate pathway. This pathway is slow and rate-limited in cardiac and skeletal muscle due to an inherently low concentration (lack of expression) of the enzymes, glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. The product of this pathway is ribose-5-phosphate, which in turn is converted to 5-phosphoribosyl-1- pyrophosphate (PRPP), the primary driver in the synthesis and salvage of purine nucleotides. No other compound can be used by the body for this metabolic purpose. Purine nucleotides (ATP and its precursors) lost due to ischemia, hypoxia, or genetic predisposition are replaced via the purine nucleotide pathway. This pathway is rate limited by the availability of ribose in tissue. Administration of exogenous ribose bypasses the rate-limiting steps in the pentose phosphate pathway, resulting in a significant acceleration of PRPP. Renewed concentration of ATP is accompanied by an increased energy potential in the cell, also known as the “energy charge.” Cardiac and skeletal muscle functions (i.e. contraction, cell wall maintenance, relaxation, polarization of the cell membrane) each require a different, quantifiable energy charge to drive or provide allosteric regulation for each function. Restoration of cellular energy charge restores function consistent with the degree of energy charge restored. D-ribose is indicated for sports and fitness activities because it helps to reduce the loss of energy during stress and accelerate energy and tissue/muscle recovery†. Endurance athletes and strength training athletes may both benefit from the effects of supplemental D-ribose. Unless our hearts have an adequate supply of ribose, they simply cannot satisfy their astonishing energy demand. Our bodies make ribose naturally, but in times of stress the need is greater than our supply to satisfy the loss of energy from our cells. That is why supplementing with d-ribose can support proper heart function and helps maintain healthy stroke volume during and after high intensity exercise†. A study by Olman et al. in 2003 showed beneficial effects on diastolic function and quality of life in compromised patients after only 3 weeks of supplemental D-ribose. Although D-ribose is a five-carbon monosaccharide, it does not raise blood sugar. Corvalen® D-ribose is non-GMO. D-ribose is rapidly and readily (~95%) absorbed with peak blood levels found within 30 – 45 minutes. Ribose not taken up by the cell is excreted unchanged in the urine. Corvalen® D-ribose is GRAS (generally recognized as safe), a determination that results only after considerable toxicology studies are performed and an expensive and time consuming FDA process is completed.

Read More

Regrowth of Neurons

by: Dr. Larry Sosna

Regrowth of neurons… also called Neuro-Regeneration is one of the most complicated

issues in the field of medical/science. The subject matter concerns the repair and

regrowth of nerve cells called neurons. The long body of the neuron is called the Axon.

This issue is divided into two imperative groups…. Peripheral Nervous System (PNS)

and the Central Nervous System (CNS) characterized by the brain and spinal cord.

When I took High School Biology the teacher made a clear and emphatic

statement. Central Nervous System neurons NEVER heal. He went on to state, that

Peripheral Neurons do heal but slowly. In Biology and Biochemistry at undergraduate

work in college both professors made the exact same statement my high school biology

teach made almost by rote. Never one to fully agree with such absolute matters in

science my questions were so penetrating and complex as to be unanswerable which

gained respect by one Professor and benign neglect from the second Professor

PNS has a method of regeneration to the injured neurons followed by the quick release

of white blood cells to fight infection. Schwann cells release neurotropic factors which

enhance regrowth of PNS neurons in several ways. The Schwann cells, prevent to

much cytotoxicity which is generally part of the healing process but illicit’s far to much

inflammation for regeneration to proceed normally. Schwann cells, also set up tubes

along side the damaged neuron. These tubes are even connected to the injured

degraded PNS neuron and a host of healing biochemicals are release by the tube to

stop neural degradation and provide healing repair to the affected injured neuron.

There are a host of outside interventions that can make this process go faster but I will

save them for Regeneration of the brain and spinal cord, which please remember is

still thought in many universities even taught to this day that CNS neurons cannot

Regeneration and Repair of the Central Nervous System (Brain and Spinal Cord. There

are two types of cells meant to serve and protect CNS neurons from injury. They are

called Astrocytes and Gllial cells. It may be hard to believe but there are many more

astrocytes in the brain then there are brain Neurons and there are some 15 to 18 billion

brain neurons. Normally, after injury to brain neurons…astrocytes support neurons by

providing antioxidant protection.

The Good the Bad and the Ugly

While the Astrocytes bring in many antioxidants to prevent free radical oxidative toxic

damage to the brain neurons…they also over-react and allow for too much inflammation

and cytotoxins from white blood cell production of Interleukin-2 and 6… this is called up-

regulation of immune cell activity. It can destroy brain neurons faster then the initial

injury to a brain or spinal neurons. This process

brings about even more inflammation to try and carry away all of the dead cells,

including neurons and astrocytes as well as white blood cell waste deposits.

Unfortunately the brain is limited in size and to much inflammation causes intracranial

pressure to the point where brain infarct is possible without making a surgical opening in

the cranium to release the pressure….that is the bad and the ugly.

How do we solve the above dire situation and bring about brain cell neuron

In some cases like bacterial or viral Encephalitis of the brain and spinal cord

many neurons can be killed or injured due to massive white blood cell

proliferation. The white blood cells kill the bacteria and virus that causes

Encephalitis but the situation is so dramatic that in order for the brain to survive

the infection killing neurons…the message which signals the white blood cells to

enter the brain becomes so up-regulated that cannot down-regulate to a normal

response thus further killing both infected neurons and the infected brain cells

both. Many people die from this berserk super up-regulated immune response

stuck on full throttle. It is a vicious repetitive cycle.

We can stop this deathly cycle by giving the patient large intravenous doses of

Gamma Globulin. Gamma Globulin consists of every type of antibody the human

body can make. Scientists are not exactly certain how and why this has such a

profound normalizing effect immunologically but it does. It is called Immuno-

modulation to the normal set point.

In both Stroke patients and infection based Encephalitis of the brain… Immuno-

Modulation to a normal set point is a must in order for neuron cell death to stop and for

Certain biochemical factors play a vital role to decrease astrocytes!  Cyclin Kinase

decreases astrocyte proliferation, increasing neuron function and recovery. Caffeic acid,

alpha- melanocyte stimulating hormone and cliostazol are all highly beneficial. They are

considered essential to a improved condition by reducing astrocyte production…this

treatment shows a decrease in neuron injury, the decrease in astrocyte high levels of

production is associated with a more positive and improved outcome moving toward

In 1984, I experienced a life/death illness called Herpetic Viral Encephalitis. It was

misdiagnosed my Manhattans most elite doctors…virtually always fatal, I lived and due

to the fact the death rate is so nearly complete I spent 3 years in bed and several more

in a wheel chair. There was no internet, no smart phones, just a nearly destroyed brain

with pain so blinding it felt as if two ice picks were being run through both eyes… and

trying to escape by pushing through the back of my skull. Luckily for me the feelers I

sent out daily… resulted in a call from Nobel prize winning doctor and scientist, Dr. Rita

Levi Montalcini who won the Nobel Prize for the discovery of Embryonic Fetal Nerve

Growth Factor in 1986. I was the first human to ever get shots of Fetal Nerve Growth

Factor in 1988 to grow back and regenerate my damaged brain neurons. Then this

magnificent woman became my mentor….I still live speaking to her shadow everyday as

she passed over at the age of almost 104.

Rita Levi-Montalcini’s discovery of a protein called ‘fetal nerve growth factor,”

which fosters the growth of nerve fibers and also plays a role in the brain and the immune

system, is one of the most important steps taken so far toward understanding how the

fantastically complex system of nerves is laid down and linked to the tissues in a developing

embryo. Her account of the adventures leading to this discovery, for which she won a Nobel

Prize in Physiology and Medicine in 1986, has a special contemporary interest. We now

know her discovery is how the brain grows all of it’s neurons when one is an embryo inside

one’s mothers womb until birth and sustains, protects and regenerates brain neurons if one

is fortunate to be born with a large amount of FNGF .  Thank goodness she was able to scale

it up through a deal with a large cutting edge biotechnology lab. in Montreal. They are the

ONLY Lab. in the world to this day that makes Dr. Rita’s original formulations.

We at AA,I are indeed incredibly fortunate to be able to have access to her formulations at

I combined her fetal nerve growth factors with very youthful blood levels of HGH (human

growth hormone…levels that would be normal for the average healthy 16 year old. Eighteen

months later, I was completely better in every way… brain regeneration wise… and in every

other health manner. The addition of HGH was my inspiration as it has been known for

many decades that it is HGH which mobilizes all of the fetal tissue growth factors such as

cardiac tissue growth factor…to do protein synthesis and thus regeneration of the heart

AND all other tissues contained within the human body. Without youthful blood levels of

HGH(say blood levels normal for a healthy 26 year old to 30 year old) and credible levels of

fetal nerve growth factor… regrowth of Neurons is unlikely in the extreme BUT with these

safe and effective blood levels of both Regrowth of every type of Neuron is probable in and

that brings amazing hope. The only Regrowth we cannot master yet is CNS spinal cord cut

in half…but the army medical scientists are getting very close.

Imagine how old we would all look, if we did not have adequate cell levels of

epithelial (skin tissue growth factor) to regenerate our SKIN? So, just like

hormones, as we age we lose our tissue growth factors…and if they cannot be

replaced to the optimal level from exogenous sources we will all be subject to

the ravages of age related illness.

Gratefully, here at AAI we have all critical tissue growth factors available to

you, our beloved family of clients.

Kindly, Larry Sosna PhD HHP

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB,

Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V,

Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian

D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Thom T,

Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics–2010

update: a report from the American Heart

Association.Circulation. 2010;121:e46–e215. [PubMed]

2. Blakeley JO, Llinas RH. Thrombolytic therapy for acute ischemic stroke. J. Neurol.

Sci. 2007;261:55–62.[PubMed]

3. Marder VJ, Jahan R, Gruber T, Goyal A, Arora V. Thrombolysis with plasmin: implications

for stroke treatment. Stroke. 2010;41:S45–S49. [PMC free article] [PubMed]

4. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment

of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N. Engl. J.

Med.2002;346:557–563. [PubMed]

5. Howells DW, Porritt MJ, Rewell SS, O’Collins V, Sena ES, van der Worp HB, Traystman RJ,

Macleod MR. Different strokes for different folks: the rich diversity of animal models of focal

cerebral ischemia. J. Cereb. Blood Flow Metab. 30:1412–1431. [PMC free article] [PubMed]

6. Kettenmann H, Ramson BR. Neuroglia. New York: Oxford University Press; 1995.

7. Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: redefining the functional

architecture of the brain. Trends Neurosci. 2003;26:523–530. [PubMed]

8. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta

Neuropathol. 2010;119:7–35.[PMC free article] [PubMed]

9. Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture:

calcium-dependent and calcium-independent mechanisms of neuronal injury. J.

Neurosci. 1993;13:3510–3524.[PubMed]

10. Swanson RA, Ying W, Kauppinen TM. Astrocyte influences on ischemic neuronal

death. Curr. Mol. Med. 2004;4:193–205. [PubMed]

11. Dringen R, Hirrlinger J. Glutathione pathways in the brain. Biol.

Chem. 2003;384:505–516. [PubMed]

12. Wilson JX. Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol.

Pharmacol.1997;75:1149–1163. [PubMed]

13. Rossi DJ, Brady JD, Mohr C. Astrocyte metabolism and signaling during brain

ischemia. Nat. Neurosci.2007;10:1377–1386. [PubMed]

14. Nedergaard M, Dirnagl U. Role of glial cells in cerebral

ischemia. Glia. 2005;50:281–286. [PubMed]

15. Ouyang YB, Voloboueva LA, Xu LJ, Giffard RG. Selective dysfunction of hippocampal

CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J.

Neurosci.2007;27:4253–4260. [PMC free article] [PubMed]

16. Xu L, Emery JF, Ouyang YB, Voloboueva LA, Giffard RG. Astrocyte targeted

overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain

ischemia. Glia. 2010;58:1042–1049.[PMC free article] [PubMed]

17. Anderson MF, Blomstrand F, Blomstrand C, Eriksson PS, Nilsson M. Astrocytes and stroke:

networking for survival? Neurochem. Res. 2003;28:293–305. [PubMed]

18. Giffard RG, Swanson RA. Ischemia-induced programmed cell death in

astrocytes. Glia. 2005;50:299–306. [PubMed]

19. Almeida A, Delgado-Esteban M, Bolanos JP, Medina JM. Oxygen and glucose deprivation

induces mitochondrial dysfunction and oxidative stress in neurones but not in astrocytes in

primary culture. J. Neurochem. 2002;81:207–217. [PubMed]

20. Xu L, Sapolsky RM, Giffard RG. Differential sensitivity of murine astrocytes and neurons

from different brain regions to injury. Exp. Neurol. 2001;169:416–424. [PubMed]

21. Zhao G, Flavin MP. Differential sensitivity of rat hippocampal and cortical astrocytes to

oxygen-glucose deprivation injury. Neurosci. Lett. 2000;285:177–180. [PubMed]

22. Lukaszevicz AC, Sampaio N, Guegan C, Benchoua A, Couriaud C, Chevalier E, Sola B,

Lacombe P, Onteniente B. High sensitivity of protoplasmic cortical astroglia to focal ischemia. J.

Cereb. Blood Flow Metab. 2002;22:289–298. [PubMed]

23. Bondarenko A, Chesler M. Rapid astrocyte death induced by transient hypoxia, acidosis, and

extracellular ion shifts. Glia. 2001;34:134–142. [PubMed]

24. Giffard RG, Monyer H, Choi DW. Selective vulnerability of cultured cortical glia to injury

by extracellular acidosis. Brain Res. 1990;530:138–141. [PubMed]

25. Swanson RA, Farrell K, Stein BA. Astrocyte energetics, function, and death under conditions

of incomplete ischemia: a mechanism of glial death in the

penumbra. Glia. 1997;21:142–153. [PubMed]

26. Tombaugh GC, Sapolsky RM. Mechanistic distinctions between excitotoxic and acidotic

hippocampal damage in an in vitro model of ischemia. J. Cereb. Blood Flow

Metab. 1990;10:527–535. [PubMed]

27. Chen Y, Swanson RA. Astrocytes and brain injury. J. Cereb. Blood Flow

Metab. 2003;23:137–149.[PubMed]

28. Lee MH, Kim H, Kim SS, Lee TH, Lim BV, Chang HK, Jang MH, Shin MC, Shin MS, Kim

CJ. Treadmill exercise suppresses ischemia-induced increment in apoptosis and cell proliferation

in hippocampal dentate gyrus of gerbils. Life Sci. 2003;73:2455–2465. [PubMed]

29. Li Y, Chopp M, Zhang ZG, Zhang RL. Expression of glial fibrillary acidic protein in areas of

focal cerebral ischemia accompanies neuronal expression of 72-kDa heat shock protein. J.

Neurol. Sci.1995;128:134–142. [PubMed]

30. Schroeter M, Schiene K, Kraemer M, Hagemann G, Weigel H, Eysel UT, Witte OW, Stoll G.

Astroglial responses in photochemically induced focal ischemia of the rat cortex. Exp Brain

Res. 1995;106:1–6.[PubMed]

31. Van Beek J, Chan P, Bernaudin M, Petit E, MacKenzie ET, Fontaine M. Glial responses,

clusterin, and complement in permanent focal cerebral ischemia in the

mouse. Glia. 2000;31:39–50. [PubMed]

32. Yamashita K, Vogel P, Fritze K, Back T, Hossmann KA, Wiessner C. Monitoring the

temporal and spatial activation pattern of astrocytes in focal cerebral ischemia using in situ

hybridization to GFAP mRNA: comparison with sgp-2 and hsp70 mRNA and the effect of

glutamate receptor antagonists. Brain Res.1996;735:285–297. [PubMed]

33. Liu D, Smith CL, Barone FC, Ellison JA, Lysko PG, Li K, Simpson IA. Astrocytic demise

precedes delayed neuronal death in focal ischemic rat brain. Brain Res. Mol. Brain

Res. 1999;68:29–41. [PubMed]

34. Dugan LL, Bruno VM, Amagasu SM, Giffard RG. Glia modulate the response of murine

cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J.

Neurosci. 1995;15:4545–4555. [PubMed]

35. Rosenberg PA, Aizenman E. Hundred-fold increase in neuronal vulnerability to glutamate

toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci.

Lett. 1989;103:162–168. [PubMed]

36. Voloboueva LA, Suh SW, Swanson RA, Giffard RG. Inhibition of mitochondrial function in

astrocytes: implications for neuroprotection. J. Neurochem. 2007;102:1383–1394. [PMC free

37. Chen JC, Hsu-Chou H, Lu JL, Chiang YC, Huang HM, Wang HL, Wu T, Liao JJ, Yeh TS.

Down-regulation of the glial glutamate transporter GLT-1 in rat hippocampus and striatum and

its modulation by a group III metabotropic glutamate receptor antagonist following transient

global forebrain ischemia. Neuro-pharmacology. 2005;49:703–714. [PubMed]

38. Yeh TH, Hwang HM, Chen JJ, Wu T, Li AH, Wang HL. Glutamate transporter function of

rat hippocampal astrocytes is impaired following the global ischemia. Neurobiol.

Dis. 2005;18:476–483.[PubMed]

39. Ito U, Hakamata Y, Kawakami E, Oyanagi K. Degeneration of astrocytic processes and their

mitochondria in cerebral cortical regions peripheral to the cortical infarction: heterogeneity of

their disintegration is closely associated with disseminated selective neuronal necrosis and

maturation of injury.Stroke. 2009;40:2173–2181. [PubMed]

40. Ito U, Hakamata Y, Kawakami E, Oyanagi K. Temporary focal cerebral ischemia results in

swollen astrocytic end-feet that compress microvessels and lead to focal cortical infarction. J.

Cereb. Blood Flow Metab. 2010 [PMC free article] [PubMed]

41. Vangeison G, Rempe DA. The Janus-faced effects of hypoxia on astrocyte

function. Neuroscientist.2009;15:579–588. [PMC free article] [PubMed]

42. Bidmon HJ, Jancsik V, Schleicher A, Hagemann G, Witte OW, Woodhams P, Zilles K.

Structural alterations and changes in cytoskeletal proteins and proteoglycans after focal cortical

ischemia. Neuroscience.1998;82:397–420. [PubMed]

43. Yasuda Y, Tateishi N, Shimoda T, Satoh S, Ogitani E, Fu-jita S. Relationship between

S100beta and GFAP expression in astrocytes during infarction and glial scar formation after mild

transient ischemia. Brain Res. 2004;1021:20–31. [PubMed]

44. Smith GM, Strunz C. Growth factor and cytokine regulation of chondroitin sulfate

proteoglycans by astrocytes. Glia. 2005;52:209–218. [PubMed]

45. Gris P, Tighe A, Levin D, Sharma R, Brown A. Transcriptional regulation of scar gene

expression in primary astrocytes. Glia. 2007;55:1145–1155. [PubMed]

46. Martinez AD, Saez JC. Regulation of astrocyte gap junctions by hypoxia-

reoxygenation. Brain Res. Brain Res. Rev. 2000;32:250–258. [PubMed]

47. Lin JH, Weigel H, Cotrina ML, Liu S, Bueno E, Hansen AJ, Hansen TW, Goldman S,

Nedergaard M. Gap-junction-mediated propagation and amplification of cell injury. Nat.

Neurosci. 1998;1:494–500.[PubMed]

48. Wang W, Redecker C, Yu ZY, Xie MJ, Tian DS, Zhang L, Bu BT, Witte OW. Rat focal

cerebral ischemia induced astrocyte proliferation and delayed neuronal death are attenuated by

cyclin-dependent kinase inhibition. J. Clin. Neurosci. 2008;15:278–285. [PubMed]

49. Forslin Aronsson S, Spulber S, Popescu LM, Winblad B, Post C, Oprica M, Schultzberg M.

alpha-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral

ischemia. Neuropeptides.2006;40:65–75. [PubMed]

50. Fang SH, Wei EQ, Zhou Y, Wang ML, Zhang WP, Yu GL, Chu LS, Chen Z. Increased

expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and

astrogliosis after focal cerebral ischemia in rats. Neuroscience. 2006;140:969–979. [PubMed]

51. Ye YL, Shi WZ, Zhang WP, Wang ML, Zhou Y, Fang SH, Liu LY, Zhang Q, Yu YP, Wei

EQ. Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic

brain injuries. Eur. J. Pharmacol. 2007;557:23–31. [PubMed]

52. Zhou Y, Fang SH, Ye YL, Chu LS, Zhang WP, Wang ML, Wei EQ. Caffeic acid ameliorates

early and delayed brain injuries after focal cerebral ischemia in rats. Acta Pharmacol.

Sin. 2006;27:1103–1110.[PubMed]

53. Chung JH, Lee EY, Jang MH, Kim CJ, Kim J, Ha E, Park HK, Choi S, Lee H, Park SH,

Leem KH, Kim EH. Acupuncture decreases ischemia-induced apoptosis and cell proliferation in

dentate gyrus of gerbils. Neurol. Res. 2007;29 Suppl 1:S23–S27. [PubMed]

54. del Zoppo GJ. Inflammation and the neurovascular unit in the setting of focal cerebral

ischemia.Neuroscience. 2009;158:972–982. [PMC free article] [PubMed]

55. Kaur C, Ling EA. Blood brain barrier in hypoxic-ischemic conditions. Curr. Neurovasc.

Res. 2008;5:71–81. [PubMed]

56. Nawashiro H, Brenner M, Fukui S, Shima K, Hallenbeck JM. High susceptibility to cerebral

ischemia in GFAP-null mice. J. Cereb. Blood Flow Metab. 2000;20:1040–1044. [PubMed]

57. Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, Nodin C, Stahlberg

A, Aprico K, Larsson K, Yabe T, Moons L, Fotheringham A, Davies I, Carmeliet P, Schwartz

JP, Pekna M, Kubista M, Blomstrand F, Mara-gakis N, Nilsson M, Pekny M. Protective role of

reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 2008;28:468–481. [PubMed]

58. Kinoshita A, Yamada K, Kohmura E, Hayakawa T. Effect of astrocyte-derived factors on

ischemic brain edema induced by rat MCA occlusion. APMIS. 1990;98:851–857. [PubMed]

59. Buchhold B, Mogoanta L, Suofu Y, Hamm A, Walker L, Kessler C, Popa-Wagner A.

Environmental enrichment improves functional and neuropathological indices following stroke

in young and aged rats.Restor. Neurol. Neurosci. 2007;25:467–484. [PubMed]

60. Keiner S, Wurm F, Kunze A, Witte OW, Redecker C. Rehabilitative therapies differentially

alter proliferation and survival of glial cell populations in the perilesional zone of cortical

infarcts. Glia.2008;56:516–527. [PubMed]

61. Popa-Wagner A, Badan I, Walker L, Groppa S, Patrana N, Kessler C. Accelerated infarct

development, cytogenesis and apoptosis following transient cerebral ischemia in aged rats. Acta

Neuropathol.2007;113:277–293. [PubMed]

62. Li Y, Chen J, Zhang CL, Wang L, Lu D, Katakowski M, Gao Q, Shen LH, Zhang J, Lu M,

Read More